# A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.

> **NCT02185040** · PHASE2 · COMPLETED · sponsor: **Celgene** · enrollment: 42 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** CC-220
- **DRUG:** CC-220
- **DRUG:** CC-220
- **DRUG:** CC-220
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02185040
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09-16
- **Primary completion:** 2018-09-25
- **Final completion:** 2018-09-25
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02185040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02185040, "A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02185040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*